Results 191 to 200 of about 37,733 (221)

Orchestration of the tumor microenvironment by citrus flavonoids: from preclinical mechanisms to translational therapeutic. [PDF]

Front Immunol
Ma S, Wang X, Li M, Wang W, Ren Y, Shen Y, Yang K, Zhang Z, Feng Z, Tang S.   +9 more
europepmc   +1 more source

A Moderate-Affinity Antibody-Drug Conjugate Targeting B7-H3 Exerts Potent Antitumor Efficacy. [PDF]

Pharmaceuticals (Basel)
Zhang Z, Zong H, Li Z, Wang S, Xiao X, Xie Y, Zhu J.   +6 more
europepmc   +1 more source

Parthenolide inhibits the progression of intrahepatic cholangiocarcinoma by promoting ferroptosis through inhibiting UBD. [PDF]

Cancer Biol Ther
Xie Y, Wang J, Zhou J, Peng Y, Wang Y, Wang Y, Song Y.   +6 more
europepmc   +1 more source

Roles of lactate and lactylation in tumor immune suppression and drug resistance. [PDF]

Front Immunol
Li J, Yang W, Xin T, Zhou Z, Liu X, Tang P, An J, Ma B, Peng F.   +8 more
europepmc   +1 more source

Synthesis and biological evaluation, network pharmacology, and molecular docking of 2-benzylidene-1-indanone derivatives as antitumor agents. [PDF]

Sci Rep
Liao X, Zhuang R, Zhuang T, Xie M, Zhou B.   +4 more
europepmc   +1 more source

Small molecules targeting the PD-1/PD-L1 axis for cancer immunotherapy. [PDF]

Theranostics
Yin JY, Liu HM, Li SL, Ji XQ, Wang JJ, Fu MJ, Liu CJ, Wang N, Lu GL, Li Y, Liu HM, Zheng YC, Dai XJ, Liu Y.   +13 more
europepmc   +1 more source

Personalized Drug Screening and Risk Assessment in Patient-Derived Gastroenteropancreatic Neuroendocrine Neoplasms.

J Clin Endocrinol Metab
Auernhammer CJ, Wang K, Maccio U, Knösel T, Hungbauer MP, Schilbach K, Maurer J, Peischer L, Reul A, Kuzmenko E, Luca E, Hamati J, Vetter D, Oberholzer J, Fritsch R, Pacak K, Grossman AB, Beuschlein F, Reincke M, Hantel C, Zitzmann K, Nölting S.   +21 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Discovering Protein-targeted Antitumor Inhibitors: Drug Screening Strategy and Molecular Mechanisms

Current Pharmaceutical Biotechnology, 2022
Jianqiang Xu
exaly